Skip to content
  • Home
  • Product
  • EIC Transition Project
  • Blog
  • Newsletter
  • Home
  • Product
  • EIC Transition Project
  • Blog
  • Newsletter

Year: 2022

Lucero awarded €1.3M Transition Grant by European Innovation Council

Lucero will ring in the new year with generous funding from the European Innovation Council (EIC) to continue the development of our 3D cell culture handling platform.

Lucero awarded Vinnova Innovative Startups Stage 2 grant

Lucero awarded 900 000 SEK Vinnova Innovative Startups Stage 2 grant to build on Stage 1 progress in preparation for an on-site pharmaceutical pilot project and Seed round funding.

Tech Update: Promising local heating data during and post-irradiation using optical tweezers

Preliminary data showed a temperature increase of less than 1 degree C in HepG2 cells during exposure to optical tweezers.

Lucero granted international project to advance microfluidic technology

Lucero has been granted a project by the European initiative, MedPhab, to accelerate the development of its novel microfluidic well plates with the help of partners, Joanneum Research and The Technical Research Center of Finland (VTT).

Lucero AB is developing the first ready-to-use 3D cell culture product tailor made for pharmaceutical drug development.

Contact Us

  • hello@lucerobio.com
  • AZ BioVentureHub, Pepparedsleden 1, SE-431 83, Mölndal
Linkedin Instagram

Copyright© LUCERO AB 2025. All rights reserved.